Literature DB >> 11207890

New hepatitis viruses: contenders and pretenders.

S Bowden1.   

Abstract

Following the development of tests for hepatitis C virus and hepatitis E virus infection, it became clear that there remained cases of hepatitis that were non-A-E. Such cases provided impetus for the search for additional hepatitis viruses and, by using molecular techniques, several candidates were identified. An enteric agent responsible for sporadic non-A and non-E hepatitis was tentatively called hepatitis F virus. However, the lack of any corroborating reports has cast doubt on its status as a true hepatitis virus. Two groups independently reported the isolation of a blood-borne virus, designated as hepatitis G virus (HGV) and GB virus C (GBV-C) by their respective discoverers. They were later shown to be isolates of the same virus. While the virus has a high prevalence in cases of non-A-E hepatitis, it also has a high prevalence in the appropriate control groups and convincing evidence for its replication in the liver is lacking. Another possible hepatitis virus, TT virus, was discovered in the blood of a patient with post-transfusion non-A-E hepatitis. By using PCR primers designed to overcome the high nucleotide sequence divergence, TT virus was found to be ubiquitous with a worldwide distribution. A disease association is thus unlikely. Most recently, a DNA virus designated as SEN-V has been announced as a major cause of non-A-E hepatitis. Based on limited data available to researchers, SEN-V is the most convincing contender for the new hepatitis virus title. However, the lessons learnt from the hepatitis virus pretenders will need to be applied to SEN-V and any future contenders.

Entities:  

Mesh:

Year:  2001        PMID: 11207890     DOI: 10.1046/j.1440-1746.2001.02405.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Prevalence of a newly identified SEN virus in China.

Authors:  Shi-Jie Mu; Juan Du; Lin-Sheng Zhan; Hai-Ping Wang; Rui Chen; Quan-Li Wang; Wen-Ming Zhao
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.

Authors:  Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Nei-Jen Hou; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

3.  Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.

Authors:  Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang; Wen-Yu Chan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  Prevalence and clinical significance of SEN virus infection in patients with non A-E hepatitis and volunteer blood donors in Shanghai.

Authors:  Zheng-Hao Tang; Xiao-Hua Chen; Yong-Sheng Yu; Guo-Qing Zang
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

5.  SEN virus infection in Egyptian patients with chronic hepatitis C and patients undergoing hemodialysis.

Authors:  Maisa Omar; Samah Saad El-Din; Nevine Fam; Manal Diab; Mohamed Shemis; Manar Raafat; Moataz Seyam; Moataz Hssan; Afkar Badawy; Maha Akl; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.